John Devane

The effects of 4‐aminopyridine in multiple sclerosis patients

C. T. Bever, Douglas Young, Paul A. Anderson et al. · Neurology · 1994 · 154 citations

Neurological Disorder, Pharmacotherapy, Translational Medicine +17

Clinical and pharmacokinetic properties of a transdermal nicotine patch

S Mulligan, Joseph Masterson, John Devane et al. · Clinical Pharmacology & Therapeutics · 1990 · 91 citations

Pharmacokinetics of an Immediate‐Release Oral Formulation of Fampridine (4‐Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury

Keith C. Hayes, Mitchell A. Katz, John Devane et al. · The Journal of Clinical Pharmacology · 2003 · 75 citations

Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study

Y. B. Bannon, J. Corish, Owen I. Corrigan et al. · European Journal of Clinical Pharmacology · 1989 · 64 citations

Tobacco Control, Transdermal Delivery, Tobacco Use +5

Artificial Neural Networks Applied to the In Vitro-In Vivo Correlation of an Extended-Release Formulation: Initial Trials and Experience

James A. Dowell, Ajaz Hussain, John Devane et al. · Journal of Pharmaceutical Sciences · 1999 · 57 citations